Equities Analysts Issue Forecasts for XFOR Q3 Earnings
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR – Free Report) – Equities researchers at Brookline Capital Management issued their Q3 2025 earnings per share estimates for shares of X4 Pharmaceuticals in a research note issued to investors on Thursday, May 1st. Brookline Capital Management analyst L. Cann forecasts that the company will post earnings per share of ($2.80) […]
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR – Free Report) – Equities researchers at Brookline Capital Management issued their Q3 2025 earnings per share estimates for shares of X4 Pharmaceuticals in a research note issued to investors on Thursday, May 1st. Brookline Capital Management analyst L. Cann forecasts that the company will post earnings per share of ($2.80) […]
